חומרים לטיפול בסרטן

• 收藏
• 分享

专利权人:

UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION

发明人:

申请号：

IL24123215

公开号：

IL241232D0

申请日:

2015.09.06

申请国别(地区):

IL

年份:

2015

代理人:

摘要：

The present invention relates to pharmaceutical compositions for treating cancer comprising BRAF inhibitors, (e.g. vemurafenib) and/or MEK inhibitor, (e.g. trametinib, RO5068760), in combination with anti-tubulin compounds of the invention or other known tubulin inhibitors, and using such compositions for treating cancer such as melanoma, drug-resistant cancer, and cancer metastasis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/